Hepatocellular carcinoma is the most commonly fatal malignant tumour worldwide. The role of androgen receptors, which have been found in hepatocellular carcinoma, is controversial. Sequence specific polymerase chain reaction (PCR) was used to quantify, for the first time, the expression of androgen receptor in four adult liver biopsy specimens (HL-A to HL-D), fetal liver, and Hep-G2 cells. The measurement of androgen receptor is expressed as a ratio (androgen receptor: 3-actin) of the value of androgen receptor to the value of a control gene, 13-actin. The value of the androgen receptor: P-actin ratios for HL-A, HL-B, HL-C, HL-D, fetal liver, and Hep-G2 were 0*37, 0-86, 0 37, 0.44, 0-87, and 0*66 respectively. To verify sequence specific amplification of the androgen receptor, the PCR androgen receptor fragment was sequenced. The resultant sequence data for both strands of the double stranded PCR androgen receptor fragment had 100% similarity with the published androgen receptor mRNA sequence (complete codons).
The presence of androgen receptor in normal liver is controversial' although its presence in hepatocellular carcinoma is thought to confer androgen responsiveness on this tumour. 23 The detection of androgen receptor has depended on ligand binding assays, which are inaccurate and insensitive because of a labile receptor protein and low values of androgen receptor expression. The recent cloning of the androgen receptor and the subsequently derived sequence data have made it possible to prepare synthetic oligonucleotide probes to the receptor, 4 and for these to be used as primers in a polymerase chain reaction (PCR). Using this approach androgen receptor expression has been detected in tissue resected from patients with hepatocellular carcinoma and in surrounding non-cancerous tissues and in one hepatoma cell line. 5 No quantitative data have been presented, however, and androgen receptor mRNA in non-cirrhotic, non-malignant liver has not been determined. Similarly, the presence of androgen receptor in fetal liver tissue has yet to be determined, but it is known that the hepatic imprinting that occurs during the late period of organogenesis results in sexual dimorphism. 6 Figure 1 shows presence of androgen receptor and ,-actin in HL-A. To identify any genomic contamination of the PCR product a reaction was performed using HL-A RNA, instead of HL-A cDNA, as the template for each new sample studied. Lack of any bands after PCR (Fig 1, lane 2) showed that there was no detectable genomic contamination. Two other controls were used to show that the reagents were not contaminated, lane 3 contained primers only and lane 4 contained HL-A cDNA but no primers, both gave negative results.
The androgen receptor PCR product was determined using both the sense and anti-sense primers (each 20 bp) by the fmol Sequencing System. The sequence of the sense and antisense strands showed 100% similarity with the published androgen receptor sequence4 from which the primers for androgen receptor were determined. The presence of androgen receptor was shown in all liver biopsy specimens studied (Figs 1 and  2 ). The expression of androgen receptor is represented at a ratio of androgen receptor: Iactin when ,-actin is used as the control 'gene expression'. The Table shows the androgen receptor: 13-actin ratios for HL-A to HL-D. Figure 3 shows the presence of androgen receptor expression in fetal liver and Hep-G2 cells and the 
